These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 29297580)

  • 41. Angiographic and Midterm Outcomes of Bioresorbable Vascular Scaffold for Coronary Bifurcation Lesions.
    Paradies V; Vlachojannis GJ; Royaards KJ; Wassing J; van der Ent M; Smits PC
    Am J Cardiol; 2018 Dec; 122(12):2035-2042. PubMed ID: 30360886
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A next-generation bioresorbable coronary scaffold system: from bench to first clinical evaluation: 6- and 12-month clinical and multimodality imaging results.
    Verheye S; Ormiston JA; Stewart J; Webster M; Sanidas E; Costa R; Costa JR; Chamie D; Abizaid AS; Pinto I; Morrison L; Toyloy S; Bhat V; Yan J; Abizaid A
    JACC Cardiovasc Interv; 2014 Jan; 7(1):89-99. PubMed ID: 24139932
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serial assessment of bioresorbable-polymer sirolimus-eluting stent by coronary angioscopy and optical coherence tomography.
    Nakamura S; Kimura S; Nakagama S; Hayashi Y; Yamamoto T; Utsugi Y; Doi J; Mizusawa M; Araki M; Sudo Y; Hishikari K; Hikita H; Takahashi A; Isobe M
    Coron Artery Dis; 2017 Sep; 28(6):530-531. PubMed ID: 28402989
    [No Abstract]   [Full Text] [Related]  

  • 44. Bioresorbable Scaffolds in Spontaneous Coronary Artery Dissection: Long-Term Follow-Up in 4 Patients.
    Camacho Freire SJ; Gómez Menchero AE; Roa Garrido J; León Jiménez J; Cardenal Piris R; Díaz Fernández JF
    Tex Heart Inst J; 2017 Dec; 44(6):405-410. PubMed ID: 29276441
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Early U.S. Experience Following FDA Approval of the ABBOTT Vascular Bioresorbable Vascular Scaffold: Optimal Deployment Technique Using High Resolution Coronary Artery Imaging.
    Rizik DG; Padaliya BB
    J Interv Cardiol; 2016 Oct; 29(5):546-548. PubMed ID: 27492571
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Footprint of a Bioresorbable Vascular Scaffold in Computed Tomography Coronary Angiogram at 5-Year Follow-up.
    Vijayvergiya R; Kanabar K; Palanivel R; Lal A; Gupta A
    J Invasive Cardiol; 2020 May; 32(5):E136-E137. PubMed ID: 32357136
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Different Absorption Time of two Absorb BVS Implanted in the Same Artery: Insights into Mechanisms of Late Scaffold Failure.
    Gąsior P; Parma R; Roleder T; Wojakowski W
    Kardiol Pol; 2018; 76(8):1277. PubMed ID: 30117525
    [No Abstract]   [Full Text] [Related]  

  • 48. First serial assessment at 6 months and 2 years of the second generation of absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study.
    Ormiston JA; Serruys PW; Onuma Y; van Geuns RJ; de Bruyne B; Dudek D; Thuesen L; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Dorange C; Veldhof S; Hebert KM; Rapoza R; Garcia-Garcia HM
    Circ Cardiovasc Interv; 2012 Oct; 5(5):620-32. PubMed ID: 23048057
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
    Onuma Y; Serruys PW; Muramatsu T; Nakatani S; van Geuns RJ; de Bruyne B; Dudek D; Christiansen E; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Garcia-Garcia HM; Veldhof S; Rapoza R; Ormiston JA
    JACC Cardiovasc Interv; 2014 Dec; 7(12):1400-11. PubMed ID: 25523532
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Complex coronary intervention with overlapping of bioresorbable scaffolds. Case report and new insights review in the use of bioresorbable vascular scaffolds guided by optical coherence tomography].
    Macías E; Amador E
    Arch Cardiol Mex; 2016; 86(2):170-4. PubMed ID: 26907194
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Blinded by the Lights: OCT-Guidance for Implantation of Magnesium-Based Bioresorbable Scaffolds?
    Seguchi M; Joner M
    Cardiovasc Revasc Med; 2022 Jul; 40():111-112. PubMed ID: 35738727
    [No Abstract]   [Full Text] [Related]  

  • 52. Bioresorbable vascular scaffolds: From patient selection to optimal scaffold implantation; tips and tricks to minimize device failure.
    Tanaka A; Jabbour RJ; Latib A; Colombo A
    Catheter Cardiovasc Interv; 2016 Nov; 88(S1):10-20. PubMed ID: 27797460
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Edge vascular response after percutaneous coronary intervention: an intracoronary ultrasound and optical coherence tomography appraisal: from radioactive platforms to first- and second-generation drug-eluting stents and bioresorbable scaffolds.
    Gogas BD; Garcia-Garcia HM; Onuma Y; Muramatsu T; Farooq V; Bourantas CV; Serruys PW
    JACC Cardiovasc Interv; 2013 Mar; 6(3):211-21. PubMed ID: 23517830
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The drug-eluting resorbable magnesium vascular scaffold in complex coronary bifurcations: insights from an in vivo multimodality imaging study.
    Bennett J; Vanhaverbeke M; Vanden Driessche N; Hiltrop N; Adriaenssens T; Desmet W; Sinnaeve P; Dubois C
    EuroIntervention; 2018 Apr; 13(17):2036-2046. PubMed ID: 28741575
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Proximal optimization technique and kissing balloon inflations with the bioresorbable vascular scaffold for coronary bifurcation percutaneous coronary intervention.
    McGeoch RJ; Tanaka K; Overgaard CB; Bezerra HG; Džavík V
    Can J Cardiol; 2014 Nov; 30(11):1461.e5-7. PubMed ID: 25442451
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preliminary Report of Clinical Outcomes After Single Crossover Bioresorbable Scaffold Implantation Without Routine Side Branch Strut Dilation.
    Tanaka A; Jabbour RJ; Kawamoto H; Mangieri A; Pagnesi M; Montalto C; Chieffo A; Carlino M; Montorfano M; Latib A; Colombo A
    Catheter Cardiovasc Interv; 2016 Nov; 88(6):865-870. PubMed ID: 27219102
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Everolimus-eluting bioresorbable vascular scaffolds versus second generation drug-eluting stents for percutaneous treatment of chronic total coronary occlusions: Technical and procedural outcomes from the GHOST-CTO registry.
    La Manna A; Chisari A; Giacchi G; Capodanno D; Longo G; Di Silvestro M; Capranzano P; Tamburino C
    Catheter Cardiovasc Interv; 2016 Nov; 88(6):E155-E163. PubMed ID: 26756959
    [TBL] [Abstract][Full Text] [Related]  

  • 58. First reported use of drug-coated balloon for bioresorbable in-scaffold restenosis.
    Latini RA; Buccheri D; Cortese B
    Catheter Cardiovasc Interv; 2017 Mar; 89(4):676-678. PubMed ID: 27649683
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Coronary bioresorbable vascular scaffolds: requiescant in pace?
    Alfonso F; Cuesta J; Rivero F
    Rev Esp Cardiol (Engl Ed); 2021 Jul; 74(7):569-572. PubMed ID: 33622635
    [No Abstract]   [Full Text] [Related]  

  • 60. Optical coherence tomography in STEMI with bioresorbable scaffold: possible cause of coronary flow impairment? A sub-study from the Prague 19 trial.
    Loffi M; Tousek P; Budesinsky T; Lisa L; Santangelo A; Widimsky P; Kocka V
    Heart Vessels; 2018 Nov; 33(11):1282-1287. PubMed ID: 29777297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.